Chief Finance Officer
01223 342200
Wendy joined NIAB in September 2021 as Chief Finance Officer.
She has over 20 years in the life science and pharmaceutical sector. After an extensive career at GSK, where she led the finance functions of numerous R&D teams and business development transactions, she was latterly the CFO of Galvani Bioelectronics, a JV between GSK and Verily Life Sciences, before joining Mundipharma as VP, innovation finance and corporate development.
Wendy holds a PhD in plant sciences from the University of Cambridge and is a Fellow of the Institute of Chartered Accountants of England and Wales.